- Sensient reported a revenue of $414.2 million for the second quarter.
- This revenue represents a 2.7% increase compared to the same quarter last year.
- The revenue met analysts’ expectations, which were estimated at $416 million.
- Adjusted Earnings Per Share (EPS) for the quarter stood at 94 cents, which is up from 77 cents in the previous year.
- Standard EPS for the quarter increased to 88 cents from 73 cents year-over-year.
- Analyst recommendations for Sensient include 2 buys and 2 holds, with no sell recommendations.
- A conference call was held to discuss the financial results.
A look at Sensient Technologies Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have assessed Sensient Technologies‘ long-term outlook using their Smart Scores, which rate the company across multiple factors. Sensient Technologies received a solid score of 3 out of 5 in Value, Dividend, Growth, and Resilience categories, indicating a stable standing in these key areas. This suggests that the company is maintaining a reasonable balance in terms of value, dividend payouts, growth potential, and resilience to market fluctuations.
Additionally, Sensient Technologies scored a high 5 in Momentum, implying strong upward momentum and positive market sentiment surrounding the company. Overall, based on these Smart Scores, Sensient Technologies appears to be well-positioned for the future, with a balanced performance across various fundamental factors and a particularly strong momentum that may be indicative of potential growth and success ahead.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
